Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

The FDA approved a new Pfizer drug for hair loss in teens.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Certain NK cell changes in blood may indicate alopecia areata progression.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

C-scores can help predict gain-of-function and loss-of-function mutations.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Topical tofacitinib is effective and safe for treating alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.